When to Conduct Hepatic Impairment Studies and When Modeling May be Enough Blog When to Conduct Hepatic Impairment Studies and When Modeling May be Enough How to decide if a hepatic impairment study is required, choose the right study design,…Certara2026年7月13日
Dosimetry tells you the dose. It doesn’t tell you the decision. ブログ Dosimetry tells you the dose. It doesn’t tell you the decision. Learn why absorbed dose data alone isn't enough for radiopharmaceutical dose optimization, and how BED,…Certara2026年7月7日
5 Key Principles of Modern PK/PD in 2026 Guide 5 Key Principles of Modern PK/PD in 2026 Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…Certara2026年6月30日
Enhancing clinical trials with real-world evidence in pregnancy research Blog リアルワールドエビデンスを活用した妊娠研究における臨床試験の強化 Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…Certara2026年6月26日
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development Announcement サターラ、Bio Venture Catalystを発表:バイオテクノロジー企業の投資リスク低減と開発加速を支援 Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…Danielle Pillsbury2026年6月23日
63 Runs and No Convergence: When RsNLME Succeeded Where Other PK/PD Solutions Couldn’t BlogCase Study 63 Runs and No Convergence: When RsNLME Succeeded Where Other PK/PD Solutions Couldn’t After 63 failed runs on a 16-ODE neutropenia model, RsNLME achieved PK/PD convergence on the…Stephen Duffull2026年6月23日
Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study Poster Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…Certara2026年6月23日
Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab Poster Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…Certara2026年6月23日
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling Poster Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…Certara2026年6月22日
Machine Learning based drug renal clearance predictor development and application Poster Machine Learning based drug renal clearance predictor development and application A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…Certara2026年6月22日